Search company, investor...
ChipCare company logo


Founded Year



Series B | Alive

Total Raised


Last Raised

$2.8M | 6 yrs ago

About ChipCare

Chipcare is a Toronto-based biotechnology company developing a point-of-care (POC) diagnostic platform which will enable sample-to-action workflow in the clinic.

Headquarters Location

555 Richmond St W, 709

Toronto, Ontario, M5V 3B1,



Missing: ChipCare's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: ChipCare's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing ChipCare

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

ChipCare is included in 5 Expert Collections, including Medical Devices.


Medical Devices

8,605 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health Monitoring & Diagnostics

3,296 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance


Digital Health

13,069 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)


Health IT

7,901 items


Clinical Encounter Tech

625 items

ChipCare Patents

ChipCare has filed 4 patents.

The 3 most popular patent topics include:

  • Analytical chemistry
  • Immune system
  • Immunology
patents chart

Application Date

Grant Date


Related Topics




Immunology, Fluid dynamics, Blood tests, Analytical chemistry, Laboratory equipment


Application Date


Grant Date



Related Topics

Immunology, Fluid dynamics, Blood tests, Analytical chemistry, Laboratory equipment



Latest ChipCare News

ChipCare picks up $2.8 mln of planned $18.8 mln Series B round

Jan 31, 2017

ChipCare picks up $2.8 mln of planned $18.8 mln Series B round November 17, 2016 By Kirk Falconer Toronto diagnostic startup ChipCare Corp has so far secured $2.8 million for its planned $18.8 million Series B financing. ChipCare said it retained San Francisco’s Biotech Alliances International as the lead investment banker for the fundraising. Founded in 2009, ChipCare leverages technology developed at the University of Toronto to deliver point-of-care diagnostics for HIV and other diseases to hard-to-reach populations. The funds raised will be used to bring its products to market. Last year, ChipCare raised a $5 million Series A financing led by Puffin Partners. Photo (seated): James Dou, co-founder and CTO, ChipCare Corp. PRESS RELEASE ChipCare Retains Biotech Alliances International to Lead Series B Capital Raise November 17, 2016 TORONTO–(BUSINESS WIRE)–ChipCare, a Toronto-based start-up diagnostic company, announced today that San Francisco-based life sciences investment bank Biotech Alliances International will serve as the lead investment banker for its $18.8 million Series B capital raise, $2.8 million of which has already been secured. ChipCare develops accessible diagnostics for inaccessible populations. Its Polvalent Analyzer (PAx) platform is the world’s first true point-of-care diagnostic device. It consists of a portable, highly mobile, easy-to-use analyzer and low cost disposable microfluidic cartridges that provides lab-quality diagnostic results in as little as 15 minutes at the point-of-care. Unlike existing devices, the PAx will be able to perform three classes of diagnostic tests and weighs less than two kilograms. “Over half of the world lives more than a day away from a central laboratory, making it difficult to access the diagnostic tests that are essential to providing medical treatment,” said James Fraser, ChipCare Chief Executive Officer. “As part of the global commitment to eliminate HIV as a global health emergency, our initial assays respond to the World Health Organization’s call for improved point-of-care diagnostics for HIV.” “This financing will help ChipCare bring its first generation analyzer and CD4 assay to market, and we are excited about the opportunity to play a role in bringing a technology that can have an important impact on world health,” said Franck Brinkhaus, CEO of Biotech Alliances International. About ChipCare Leveraging technology developed at the University of Toronto, ChipCare is a point-of-care (POC) diagnostics company that will bring lifesaving diagnostics to the hardest-to-reach populations. The ChipCare PAx (Polyvalent Analyzer) is a portable, easy-to-used multiplex reader that provides lab-quality results in as little as 15 minutes employing low-cost microfluidic disposable cartridges. About Biotech Alliances International Biotech Alliances International, Inc. is a San Francisco-based investment bank serving life sciences companies, private equity and venture capital funds. It provides independent financial and strategic advice including corporate finance, mergers & acquisitions, partnering & licensing, deal sourcing and strategic consulting. Contacts

ChipCare Frequently Asked Questions (FAQ)

  • When was ChipCare founded?

    ChipCare was founded in 2009.

  • Where is ChipCare's headquarters?

    ChipCare's headquarters is located at 555 Richmond St W,, Toronto.

  • What is ChipCare's latest funding round?

    ChipCare's latest funding round is Series B.

  • How much did ChipCare raise?

    ChipCare raised a total of $9.85M.

  • Who are the investors of ChipCare?

    Investors of ChipCare include Biotech Alliances International, Maple Leaf Angels, Toronto Innovation Acceleration Partners, Winfield Venture Group, Epic Capital Management and 6 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.